1. Home
  2. IIIN vs CELC Comparison

IIIN vs CELC Comparison

Compare IIIN & CELC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IIIN
  • CELC
  • Stock Information
  • Founded
  • IIIN 1953
  • CELC 2011
  • Country
  • IIIN United States
  • CELC United States
  • Employees
  • IIIN N/A
  • CELC N/A
  • Industry
  • IIIN Steel/Iron Ore
  • CELC Medical Specialities
  • Sector
  • IIIN Industrials
  • CELC Health Care
  • Exchange
  • IIIN Nasdaq
  • CELC Nasdaq
  • Market Cap
  • IIIN 515.0M
  • CELC 440.7M
  • IPO Year
  • IIIN N/A
  • CELC 2017
  • Fundamental
  • Price
  • IIIN $29.19
  • CELC $13.15
  • Analyst Decision
  • IIIN
  • CELC Strong Buy
  • Analyst Count
  • IIIN 0
  • CELC 6
  • Target Price
  • IIIN N/A
  • CELC $30.17
  • AVG Volume (30 Days)
  • IIIN 175.7K
  • CELC 175.7K
  • Earning Date
  • IIIN 01-16-2025
  • CELC 03-26-2025
  • Dividend Yield
  • IIIN 3.81%
  • CELC N/A
  • EPS Growth
  • IIIN N/A
  • CELC N/A
  • EPS
  • IIIN 0.99
  • CELC N/A
  • Revenue
  • IIIN $537,193,000.00
  • CELC N/A
  • Revenue This Year
  • IIIN $19.26
  • CELC N/A
  • Revenue Next Year
  • IIIN $8.52
  • CELC N/A
  • P/E Ratio
  • IIIN $30.34
  • CELC N/A
  • Revenue Growth
  • IIIN N/A
  • CELC N/A
  • 52 Week Low
  • IIIN $23.60
  • CELC $10.35
  • 52 Week High
  • IIIN $38.40
  • CELC $22.19
  • Technical
  • Relative Strength Index (RSI)
  • IIIN 50.37
  • CELC 60.85
  • Support Level
  • IIIN $30.52
  • CELC $12.55
  • Resistance Level
  • IIIN $31.45
  • CELC $13.25
  • Average True Range (ATR)
  • IIIN 0.93
  • CELC 0.68
  • MACD
  • IIIN 0.02
  • CELC 0.14
  • Stochastic Oscillator
  • IIIN 39.38
  • CELC 85.79

About IIIN Insteel Industries Inc.

Insteel Industries Inc manufactures steel wire reinforcing products for concrete construction applications. It manufactures and markets PC strand and welded wire reinforcement, including ESM, concrete pipe reinforcement, and standard welded wire reinforcement. The company's products are sold to manufacturers of concrete products that are used in nonresidential construction. Its concrete reinforcing products consist of two product lines: PC strand and WWR. Insteel generates its geographical revenue from the United States.

About CELC Celcuity Inc.

Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.

Share on Social Networks: